Company overview
EyePoint Pharmaceuticals, Inc. engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible Durasert E technology for sustained intraocular drug delivery. Its lead product candidate is DURAVYU, an investigational sustained delivery treatment for VEGF-mediated retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor with Durasert E which is in Phase 3 clinical trials for wet age-related macular degeneration (wet AMD), non-proliferative diabetic retinopathy (NPDR), and diabetic macular edema (DME). The company's pipeline programs also include EYP-2301, a promising TIE-2 agonist formulated in Durasert E that is in pre-clinical development phase for potentially improve outcomes in serious retinal diseases. The company was formerly known as pSivida Corp. and changed its name to EyePoint Pharmaceuticals, Inc. in March 2018. EyePoint Pharmaceuticals, Inc. was incorporated in 1987 and is headquartered in Watertown, Massachusetts.
Daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-08. TTM means trailing twelve months. Use the market date when comparing EYPT with another company.
| Daily close (USD) | $3.46 |
| Market capitalization (USD) | $298,293,997.48 |
| Price / earnings (TTM) | Not reported |
| Price / book | 1.79 |
No matching rows. Clear the filter to see all records.
Read EYPT's valuation metrics
Company size
EyePoint, Inc. Common Stock's recorded market capitalization is $298,293,997.48. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
EYPT's recorded price-to-book ratio is 1.79. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research EyePoint, Inc. Common Stock with Aurora
Use the snapshot above to ask a specific question about EYPT. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow EYPT's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.